Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: A systematic review and meta-analysis.
暂无分享,去创建一个
D. Witt | M. Monreal | D. Siegal | M. Crowther | C. Chai-Adisaksopha | C. Hillis | D. Little | Derek H. W. Little
[1] N. Sengupta,et al. Resumption of Warfarin After Hospitalization for Lower Gastrointestinal Bleeding and Mortality Benefits , 2017, Journal of clinical gastroenterology.
[2] E. Antman,et al. Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial , 2017, Journal of the American Heart Association.
[3] M. Bottai,et al. Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding , 2016, Thrombosis and Haemostasis.
[4] M. Hernán,et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions , 2016, British Medical Journal.
[5] P. Kirchhof,et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European heart journal.
[6] G. Guyatt,et al. When and how to update systematic reviews: consensus and checklist , 2016, British Medical Journal.
[7] N. Bhala,et al. Tu1354 Maintenance of Antithrombotic Therapy Post Endoscopy for Acute Upper Gastrointestinal Bleeding Is Associated With Improved Clinical Outcomes , 2016 .
[8] J. Beyer-Westendorf,et al. Pattern and Management of ISTH Major Bleeding Complications with Direct Oral Anticoagulants - Results of the Prospective Dresden Noac Registry (NCT01588119) , 2015 .
[9] D. Singer,et al. Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial. , 2015, Journal of the American College of Cardiology.
[10] J. Olesen,et al. Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study , 2015, BMJ : British Medical Journal.
[11] F. Dentali,et al. Management of anticoagulation in patients with acute gastrointestinal bleeding. , 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[12] D. Witt,et al. Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding , 2015, Thrombosis and Haemostasis.
[13] N. Calo,et al. 787 Risk of Death and Thromboembolism in Patients That Do Not Resume Anticoagulation After an Episode of Peptic Ulcer Bleeding , 2015 .
[14] E. Tapper,et al. The Risks of Thromboembolism Vs. Recurrent Gastrointestinal Bleeding after Interruption of Systemic Anticoagulation in Hospitalized Inpatients With Gastrointestinal Bleeding: A Prospective Study , 2015, The American Journal of Gastroenterology.
[15] Eyal Shahar,et al. Stroke incidence and mortality trends in US communities, 1987 to 2011. , 2014, JAMA.
[16] G. Guyatt,et al. How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature. , 2014, JAMA.
[17] P. Hsu,et al. Gastrointestinal Hemorrhage in Warfarin Anticoagulated Patients: Incidence, Risk Factor, Management, and Outcome , 2014, BioMed research international.
[18] Alexander Parkhomenko,et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials , 2014, The Lancet.
[19] Zaid Alirhayim,et al. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation. , 2014, The American journal of cardiology.
[20] W. Ageno,et al. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. , 2012, Archives of internal medicine.
[21] L. Køber,et al. Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation. , 2012, European heart journal.
[22] S. G. Kim,et al. Risks related with withholding and resuming anticoagulation in patients with non‐variceal upper gastrointestinal bleeding while on warfarin therapy , 2012, International journal of clinical practice.
[23] G. Guyatt,et al. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. , 2011, Journal of clinical epidemiology.
[24] J. Douketis,et al. The clinical impact of bleeding during oral anticoagulant therapy , 2011, Journal of Thrombosis and Thrombolysis.
[25] S. Wiedmann,et al. Three-month stroke outcome , 2010, Neurology.
[26] P. Wells,et al. Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism , 2010, Annals of Internal Medicine.
[27] J. Ioannidis,et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].
[28] M. Monreal,et al. Clinical outcome of patients with major bleeding after venous thromboembolism , 2008, Thrombosis and Haemostasis.
[29] M. Aguilar,et al. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.
[30] John Spandorfer,et al. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding. , 2006, Archives of internal medicine.
[31] James Douketis,et al. Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism , 2003, Annals of Internal Medicine.
[32] S. Borzak,et al. How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage? , 2001, Chest.
[33] F Clerc,et al. Long-term results of valve replacement with the St. Jude Medical prosthesis. , 1995, The Journal of thoracic and cardiovascular surgery.